NEA Management Company, LLC
Q4 2025 13F Holdings
- Locationtimonium, MD
- Num holdings
27
- Value ($000)
$1,961,137
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001512848
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Celcuity Inc. | COM | 15102K100 | $352.64M | 18 % | 3,535,561 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $311.48M | 16 % | 2,909,956 | ||
Arcellx, Inc. | COMMON STOCK | 03940C100 | $198.55M | 10 % | 3,045,262 | ||
Trevi Therapeutics, Inc. | COM | 89532M101 | $165.54M | 8 % | 13,222,228 | ||
Savara, Inc. | COM | 805111101 | $147.56M | 8 % | 24,471,264 | ||
Zenas BioPharma, Inc. | COM | 98937L105 | $127.93M | 7 % | 3,523,219 | ||
Monte Rosa Therapeutics, Inc. | COM | 61225M102 | $120.62M | 6 % | 7,692,298 | ||
MBX Biosciences, Inc. | COM | 55287L101 | $114M | 6 % | 3,614,486 | ||
Coursera, Inc. | COM | 22266M104 | $94.71M | 5 % | 12,867,769 | ||
Aurinia Pharmaceuticals, Inc. | COM | 05156V102 | $63.32M | 3 % | 3,969,834 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100